Full-Time

Salesforce Developer

Global Banking & Markets, CRM Engineering

Updated on 3/14/2025

Goldman Sachs

Goldman Sachs

Global investment banking and asset management firm

No salary listed

Junior, Mid

Company Historically Provides H1B Sponsorship

Salt Lake City, UT, USA

Category
Backend Engineering
Software Engineering
Required Skills
Salesforce
Data Analysis
Requirements
  • Advanced degree in Computer Science, Data Analytics, or similar technical domain.
  • Strong analytical and problem solving skills.
  • Self-directed and self-motivated.
  • Ability to build consensus with others and work independently to complete tasks on-time.
  • 2+ years of prior experience with Salesforce software ecosystem including Lightning, Apex, Integrations, and Visual Force.
  • Salesforce Administrator and Salesforce Platform Developer certifications.
Desired Qualifications
  • Experience in Finance or FinTech industry.
  • Experience with Java.
  • Experience with data modeling.
  • Experience with process modeling tools and best practices.
  • Exposure to ETL tools.

Goldman Sachs provides a variety of financial services, including investment banking, asset management, and securities trading. The firm offers advisory services for mergers and acquisitions, helps clients with underwriting securities, and manages assets for a diverse range of clients, including corporations, financial institutions, governments, and wealthy individuals. Revenue is earned through fees for these advisory services, trading commissions, and asset management fees. Goldman Sachs distinguishes itself from competitors by its extensive experience and commitment to social responsibility, which includes initiatives to support small businesses and promote racial equity. The company's goal is to deliver high-quality financial services while also making a positive impact on society.

Company Size

N/A

Company Stage

IPO

Headquarters

New York City, New York

Founded

1869

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased focus on AI-driven platforms enhances Goldman Sachs' data extraction and valuation capabilities.
  • Goldman Sachs' investment in digital nutritional therapy aligns with growing health-focused financial markets.
  • Involvement in urban infrastructure projects boosts Goldman Sachs' brand in sustainable investments.

What critics are saying

  • AI-driven platforms like 73 Strings could disrupt traditional investment management services.
  • Potential overexposure to high-risk investments in emerging sectors like digital nutritional therapy.
  • Regulatory scrutiny from investments in controversial sectors like stormwater infrastructure.

What makes Goldman Sachs unique

  • Goldman Sachs excels in diverse financial services, including investment banking and asset management.
  • The firm is committed to social responsibility, supporting small businesses and racial equity.
  • Goldman Sachs has a strong global presence, serving corporations, governments, and high-net-worth individuals.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Sick Leave

Paid Holidays

Professional Development Budget

Company News

PR Newswire
Mar 4th, 2025
Mews Secures Major Investment to Cement Industry Leadership and Redefine Hospitality Management

/PRNewswire/ -- Mews, the leading hospitality technology platform, today announced it has raised $75 million, led by Tiger Global, a leading global investment...

Business Wire
Feb 20th, 2025
73 Strings Secures $55m Series B Led by Growth Equity at Goldman Sachs Alternatives

73 Strings, the financial intelligence platform using AI to revolutionize data extraction, monitoring, and valuation for the $17.6 Trillion AUM Altern

Business Wire
Feb 15th, 2025
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 mil

Business Wire
Feb 14th, 2025
Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines

Newleos Therapeutics, Inc., a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, today anno

Tines
Feb 11th, 2025
Announcing our $125M Series C fundraise | Tines

Learn how we’re accelerating investments in product innovation, world-class support, value-adding AI features, and enhanced security capabilities.